NCT03327961 Scaffold in Emilia Romagna and in the MAGIC Network
| NCT ID | NCT03327961 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital of Ferrara |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,111 participants |
| Start Date | 2017-12-02 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,111 participants in total. It began in 2017-12-02 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The prospective study will investigate the clinical performance and long-term safety of scaffold implantation in a real world regional setting. The protocol includes two different networks. The first network includes all cath-labs in the Emilia-Romagna region (SHERPA). The second includes the centers partecipating into the MAGIC retrospective study. Both networks joined into the prospective SHERPA-MAGIC project. Investigators from both networks agreed in indications and strategy implanatation described by the protocol. In each center, after IRB approval, the patients will be enrolled according to established criteria.
Eligibility Criteria
Inclusion Criteria: * subjects \>18 years * sign of the patients informed consent * implanation of at least one scaffold Exclusion Criteria: * inability to garantuee at least one year follow-up * inabiliuty to garantuee at least one year compliance to dual antiplatelet regimen
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03327961 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03327961 currently recruiting?
Yes, NCT03327961 is actively recruiting participants. Contact the research team at ldlvnc@unife.it for enrollment information.
Where is the NCT03327961 trial being conducted?
This trial is being conducted at Agrigento, Italy, Treviglio, Italy, Bologna, Italy, Bologna, Italy and 11 additional locations.
Who is sponsoring the NCT03327961 clinical trial?
NCT03327961 is sponsored by University Hospital of Ferrara. The trial plans to enroll 1,111 participants.